307 related articles for article (PubMed ID: 26313852)
1. Treatment of inflammatory myopathy: emerging therapies and therapeutic targets.
Moghadam-Kia S; Aggarwal R; Oddis CV
Expert Rev Clin Immunol; 2015; 11(11):1265-75. PubMed ID: 26313852
[TBL] [Abstract][Full Text] [Related]
2. Myositis in clinical practice-relevance of new antibodies.
Moghadam-Kia S; Aggarwal R; Oddis CV
Best Pract Res Clin Rheumatol; 2018 Dec; 32(6):887-901. PubMed ID: 31427061
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic advances in myositis.
Aggarwal R; Oddis CV
Curr Opin Rheumatol; 2012 Nov; 24(6):635-41. PubMed ID: 22955021
[TBL] [Abstract][Full Text] [Related]
4. Update on the pharmacological treatment of adult myositis.
Oddis CV
J Intern Med; 2016 Jul; 280(1):63-74. PubMed ID: 27098592
[TBL] [Abstract][Full Text] [Related]
5. Modern Therapies for Idiopathic Inflammatory Myopathies (IIMs): Role of Biologics.
Moghadam-Kia S; Oddis CV; Aggarwal R
Clin Rev Allergy Immunol; 2017 Feb; 52(1):81-87. PubMed ID: 26767526
[TBL] [Abstract][Full Text] [Related]
6. [Therapeutic strategy in inflammatory myopathies (polymyositis, dermatomyositis, overlap myositis, and immune-mediated necrotizing myopathy)].
Tournadre A
Rev Med Interne; 2014 Jul; 35(7):466-71. PubMed ID: 24144868
[TBL] [Abstract][Full Text] [Related]
7. Calcineurin inhibitors in a cohort of patients with antisynthetase-associated interstitial lung disease.
Labirua-Iturburu A; Selva-O'Callaghan A; Martínez-Gómez X; Trallero-Araguás E; Labrador-Horrillo M; Vilardell-Tarrés M
Clin Exp Rheumatol; 2013; 31(3):436-9. PubMed ID: 23465087
[TBL] [Abstract][Full Text] [Related]
8. Tacrolimus in idiopathic inflammatory myopathy-associated interstitial lung disease: defining roles and responders.
Gordon P; Gooptu B
Rheumatology (Oxford); 2015 Jan; 54(1):3-4. PubMed ID: 25342374
[No Abstract] [Full Text] [Related]
9. [Treatment of steroid-resistant polymyositis and dermatomyositis].
Mimura T; Kanda H; Kubo K
Nihon Rinsho; 2001 Oct; 59(10):2062-70. PubMed ID: 11676154
[TBL] [Abstract][Full Text] [Related]
10. Rituximab in the Treatment of Jo1 Antibody-associated Antisynthetase Syndrome: Anti-Ro52 Positivity as a Marker for Severity and Treatment Response.
Bauhammer J; Blank N; Max R; Lorenz HM; Wagner U; Krause D; Fiehn C
J Rheumatol; 2016 Aug; 43(8):1566-74. PubMed ID: 27252419
[TBL] [Abstract][Full Text] [Related]
11. Treatment of idiopathic inflammatory myopathies.
Amato AA; Griggs RC
Curr Opin Neurol; 2003 Oct; 16(5):569-75. PubMed ID: 14501840
[TBL] [Abstract][Full Text] [Related]
12. Favorable outcomes with tacrolimus in two patients with refractory interstitial lung disease associated with polymyositis/dermatomyositis.
Ochi S; Nanki T; Takada K; Suzuki F; Komano Y; Kubota T; Miyasaka N
Clin Exp Rheumatol; 2005; 23(5):707-10. PubMed ID: 16173253
[TBL] [Abstract][Full Text] [Related]
13. Myositis-associated Interstitial Lung Disease: Predictors of Failure of Conventional Treatment and Response to Tacrolimus in a US Cohort.
Sharma N; Putman MS; Vij R; Strek ME; Dua A
J Rheumatol; 2017 Nov; 44(11):1612-1618. PubMed ID: 28864644
[TBL] [Abstract][Full Text] [Related]
14. Advances in immunosuppressive therapy.
Marder W; McCune WJ
Semin Respir Crit Care Med; 2007 Aug; 28(4):398-417. PubMed ID: 17764058
[TBL] [Abstract][Full Text] [Related]
15. [Dermatomyositis and polymyositis: clinical aspects and treatment].
Hachulla E
Ann Med Interne (Paris); 2001 Nov; 152(7):455-64. PubMed ID: 11965087
[TBL] [Abstract][Full Text] [Related]
16. Antisynthetase syndrome: not just an inflammatory myopathy.
Chatterjee S; Prayson R; Farver C
Cleve Clin J Med; 2013 Oct; 80(10):655-66. PubMed ID: 24085811
[TBL] [Abstract][Full Text] [Related]
17. Intravenous cyclophosphamide improves functional outcomes in interstitial lung disease related to idiopathic inflammatory myopathies.
Moreno-Torres V; Martín-Iglesias D; Vivero F; González-Echavarri C; García-Moyano M; Enghelmayer JI; Malfante P; Gaser A; Ruiz-Irastorza G;
Semin Arthritis Rheum; 2023 Apr; 59():152164. PubMed ID: 36773521
[TBL] [Abstract][Full Text] [Related]
18. Treatment of inflammatory muscle disease in adults.
Tournadre A; Dubost JJ; Soubrier M
Joint Bone Spine; 2010 Oct; 77(5):390-4. PubMed ID: 20627789
[TBL] [Abstract][Full Text] [Related]
19. Immunosuppressive drug therapy.
McCune WJ; Vallance DK; Lynch JP
Curr Opin Rheumatol; 1994 May; 6(3):262-72. PubMed ID: 8060760
[TBL] [Abstract][Full Text] [Related]
20. Cyclosporine treatment for polymyositis/dermatomyositis: is it possible to rescue the deteriorating cases with interstitial pneumonitis?
Maeda K; Kimura R; Komuta K; Igarashi T
Scand J Rheumatol; 1997; 26(1):24-9. PubMed ID: 9057798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
